The EHA Foundation is a not-for-profit organisation established by the European Hematology Association (EHA) in 2025. Its creation allows EHA to further its mission through dedicated programs in research, education, and access to care. The Foundation operates as an independent charitable entity, while working in close affiliation with EHA and upholding EHA’s values and high standards.
Vision
Innovating hematology, advancing global education, ensuring care for all.
Mission
Advancing hematology by facilitating clinical research, upholding the highest standards in accredited education, and promoting equitable access to care.
Board
The Foundation is led by a Board composed of leading hematology professionals, including several EHA Board members and independent experts.
In addition, a Supervisory Board provides oversight and guidance, reinforcing accountability and trust in the Foundation’s operations.
In careful alignment with our statutes, the board:
- Deals with issues related to policy
- Establishes our goals and the strategic direction
Current Board members
Foundation Board:
Julio Delgado, MD, PhD
Head, Onco-Immunotherapy Unit & Consultant Hematologist, Hospital Clínic Barcelona; Associate Professor, University of Barcelona
Daniel Coriu, MD, PhD
Professor of Hematology, Carol Davila University of Medicine & Pharmacy; Director, Center for Hematology & Bone Marrow Transplantation, Fundeni Clinical Institute Bucharest
Maria Teresa Voso, MD
Professor of Hematology, University of Rome Tor Vergata; Head, Oncohematology Research & Diagnostic Laboratory MDS/AML
Supervisory Board:
Evangelos Terpos, MD, PhD
Professor of Hematology, Department of Clinical Therapeutics, National & Kapodistrian University of Athens
Martin Dreyling, MD
Professor of Medicine & Head of the Lymphoma Program, Department of Medicine III, LMU Hospital Munich
Chiara Bonini, MD
Professor of Hematology, Università Vita-Salute San Raffaele (Milan); Head, Experimental Hematology Unit, IRCCS Ospedale San Raffaele